Development of bacteriophages as alternatives to antibiotics
开发噬菌体作为抗生素的替代品
基本信息
- 批准号:RGPIN-2018-04355
- 负责人:
- 金额:$ 5.25万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Bacteriophages (or phages) are viruses that specifically infect and kill bacteria. Most phages are comprised of an icosahedral head containing a double-stranded DNA genome, attached to a phage tail responsible for adhering to a surface receptor on the host bacterium. During infection the phage genome is delivered to the cell interior where phage proteins are expressed. The phage tail / host cell receptor interface is thought to be one of the most specific “lock and key” interactions in the biological world, and gives phages their exquisite specificity for bacterial cells. Molecular analysis of these mechanisms can provide insight into how phages defeat their bacterial hosts, and suggest successful strategies man can utilize to combat pathogenic bacteria. With the worldwide overuse of chemical antibiotics since the mid-20th century, we have recently observed a rapid increase in the number of bacteria presenting extreme antibiotic resistance, including bacteria of the genera Burkholderia and Stenotrophomonas. Therefore, the search for alternatives to antibiotics has gained importance, and the application of or treatment with phages has demonstrated promise, not only for human infections, but also for animal and plant diseases caused by bacteria. Numerous experimental studies have established phage treatment efficacy in both agricultural and clinical settings, and recently, instances of human lives being saved from pathogenic bacteria has been documented in North America. These results suggest that with further development, phages will become a useful addition to medicines available to complement or replace traditional antibiotics. The objective of this proposal is to examine phage mechanisms of attachment to bacterial receptors, and with this knowledge, optimize phages for application against highly antibiotic resistant bacteria. To decrease the evolution of phage resistance, multiple phages with different receptors will be combined, and phages that target virulence factors will promote anti-virulence in bacteria mutating to escape phage attack. Phages can be modified using molecular biology to eliminate problematic genes / proteins, and improved by adding genes that encode proteins that enhance activity (e.g. broaden host range, penetrate biofilms). Molecular characterization of the phage receptor-binding proteins, and the bacterium's surface receptors will provide important insights into the nature of the mechanisms involved in phage:bacterium interactions. The knowledge gained through this work will create opportunities to engineer phages against pathogenic and antibiotic resistant bacteria for a variety of novel biotechnological applications, including biosensors, relevant to agriculture, industry, and healthcare.
噬菌体(或噬菌体)是专门感染和杀死细菌的病毒。大多数噬菌体由包含双链DNA基因组的二十面体头部组成,附着在噬菌体尾部,负责附着在宿主细菌的表面受体上。在感染过程中,噬菌体基因组被传递到细胞内部,在那里噬菌体蛋白被表达。噬菌体尾部/宿主细胞受体界面被认为是生物世界中最特异性的“锁与钥匙”相互作用之一,并赋予噬菌体对细菌细胞的精致特异性。对这些机制的分子分析可以深入了解噬菌体如何击败它们的细菌宿主,并提出人类可以利用的成功策略来对抗致病菌。自20世纪中期以来,随着世界范围内化学抗生素的过度使用,我们最近观察到,呈现极端抗生素耐药性的细菌数量迅速增加,包括伯克霍尔德氏菌属和窄养单胞菌属细菌。因此,寻找抗生素的替代品变得越来越重要,噬菌体的应用或治疗不仅对人类感染,而且对由细菌引起的动物和植物疾病也显示出希望。许多实验研究已经在农业和临床环境中确立了噬菌体治疗的有效性,最近,在北美已经记录了从致病菌中拯救人类生命的实例。这些结果表明,随着进一步的发展,噬菌体将成为一种有用的药物补充或替代传统抗生素。本提案的目的是研究噬菌体附着于细菌受体的机制,并利用这些知识,优化噬菌体用于对抗高度耐药细菌的应用。为了减少噬菌体耐药性的进化,将具有不同受体的多个噬菌体组合在一起,靶向毒力因子的噬菌体将促进细菌的抗毒力突变以逃避噬菌体的攻击。噬菌体可以使用分子生物学来修饰,以消除有问题的基因/蛋白质,并通过添加编码增强活性的蛋白质的基因来改进(例如,扩大宿主范围,穿透生物膜)。噬菌体受体结合蛋白和细菌表面受体的分子特性将为噬菌体与细菌相互作用机制的本质提供重要的见解。通过这项工作获得的知识将为设计噬菌体对抗致病性和抗生素耐药细菌创造机会,用于各种新型生物技术应用,包括与农业、工业和医疗保健相关的生物传感器。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dennis, Jonathan其他文献
Chromatin dynamics: Nucleosome occupancy and sensitivity as determinants of gene expression and cell fate.
- DOI:
10.46439/cancerbiology.2.024 - 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Benoit, Jane;Sheikhbahaei, Mahdi Khadem;Dennis, Jonathan - 通讯作者:
Dennis, Jonathan
Image Feature Representation of the Subband Power Distribution for Robust Sound Event Classification
- DOI:
10.1109/tasl.2012.2226160 - 发表时间:
2013-02-01 - 期刊:
- 影响因子:0
- 作者:
Dennis, Jonathan;Tran, Huy Dat;Chng, Eng Siong - 通讯作者:
Chng, Eng Siong
Spectrogram Image Feature for Sound Event Classification in Mismatched Conditions
- DOI:
10.1109/lsp.2010.2100380 - 发表时间:
2011-02-01 - 期刊:
- 影响因子:3.9
- 作者:
Dennis, Jonathan;Tran, Huy Dat;Li, Haizhou - 通讯作者:
Li, Haizhou
Dennis, Jonathan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dennis, Jonathan', 18)}}的其他基金
Development of bacteriophages as alternatives to antibiotics
开发噬菌体作为抗生素的替代品
- 批准号:
RGPIN-2018-04355 - 财政年份:2021
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Development of bacteriophages as alternatives to antibiotics
开发噬菌体作为抗生素的替代品
- 批准号:
RGPIN-2018-04355 - 财政年份:2020
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Development of bacteriophages as alternatives to antibiotics
开发噬菌体作为抗生素的替代品
- 批准号:
RGPIN-2018-04355 - 财政年份:2019
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Development of bacteriophages as alternatives to antibiotics
开发噬菌体作为抗生素的替代品
- 批准号:
RGPIN-2018-04355 - 财政年份:2018
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Mechanisms of bacterial resistance
细菌耐药机制
- 批准号:
238414-2010 - 财政年份:2017
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Mechanisms of bacterial resistance
细菌耐药机制
- 批准号:
238414-2010 - 财政年份:2015
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Mechanisms of bacterial resistance
细菌耐药机制
- 批准号:
238414-2010 - 财政年份:2014
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Mechanisms of bacterial resistance
细菌耐药机制
- 批准号:
238414-2010 - 财政年份:2013
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Mechanisms of bacterial resistance
细菌耐药机制
- 批准号:
238414-2010 - 财政年份:2012
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
Mechanisms of bacterial resistance
细菌耐药机制
- 批准号:
238414-2010 - 财政年份:2011
- 资助金额:
$ 5.25万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
- 批准号:82371251
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 5.25万 - 项目类别:
Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
开发用于常规生成正交 GPCR 靶向纳米抗体的集成管道
- 批准号:
10603669 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
DRUG DISCOVERY BY DIRECTED EVOLUTION IN MAMMALIAN CELLS
通过哺乳动物细胞定向进化发现药物
- 批准号:
10644749 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
A novel peptide assay for hepcidin clinical monitoring
一种用于铁调素临床监测的新型肽测定方法
- 批准号:
10698746 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Novel, Targeted Method for Bacteriophage Purification
噬菌体纯化的新型靶向方法
- 批准号:
10698983 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents
纳米荧光素酶报告噬菌体用于快速表征下一代抗分枝杆菌药物的耐药性
- 批准号:
10593796 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Catch and Release Radiolabeled Peptides: a new technology for radiotracer development
捕获并释放放射性标记肽:放射性示踪剂开发的新技术
- 批准号:
10593475 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Exploiting Pf phage superinfection to lower Pseudomonas aeruginosa virulence via evolutionary tradeoffs
利用 Pf 噬菌体重复感染通过进化权衡降低铜绿假单胞菌毒力
- 批准号:
10748681 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Bacteriophage virus-like particle based vaccines against oxycodone
基于噬菌体病毒样颗粒的羟考酮疫苗
- 批准号:
10750819 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别: